Aspire Biopharma Holdings, Inc. (ASBP) Gross Margin (2025 - 2026)
Aspire Biopharma Holdings (ASBP) recorded Gross Margin of -47.68% in Q2 2026, down 67.96 percentage points from the prior quarter.
Powered by 
Analysis
Aspire Biopharma Holdings, Inc. (ASBP) Gross Margin (2025 - 2026) Analysis & Trends
On a TTM basis, Aspire Biopharma Holdings' Gross Margin came in at -25.04% as of Jun 30, 2026; for FY2025, it came in at -1.87%.
- Per Business Quant, the preceding three quarters came in at 20.28% (Q1 2026), -23.47% (Q4 2025) and 45.54% (Q3 2025).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.68% |
| Mar 31, 2026 | 20.28% |
| Dec 31, 2025 | -23.47% |
| Sep 30, 2025 | 45.54% |
API Access
Aspire Biopharma Holdings, Inc. Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ASBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ASBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ASBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();